Jimmi Nielsen
Jimmi Nielsen
Mental Health Centre Glostrup, Copenhagen University
Bekræftet mail på regionh.dk
Citeret af
Citeret af
Genome-wide association study identifies five new schizophrenia loci
Nature genetics 43 (10), 969-976, 2011
Suicide risk in schizophrenia: learning from the past to change the future
M Pompili, XF Amador, P Girardi, J Harkavy-Friedman, M Harrow, ...
Annals of general psychiatry 6 (1), 1-22, 2007
Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naive schizophrenia patients
J Nielsen, S Skadhede, CU Correll
Neuropsychopharmacology 35 (9), 1997-2004, 2010
Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?
J Nielsen, CU Correll, P Manu, JM Kane
The Journal of clinical psychiatry 74 (6), 20799, 2013
Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis
B Galling, A Roldan, RE Nielsen, J Nielsen, T Gerhard, M Carbon, ...
JAMA psychiatry 73 (3), 247-259, 2016
Psychiatrists’ attitude towards and knowledge of clozapine treatment
J Nielsen, M Dahm, H Lublin, D Taylor
Journal of psychopharmacology 24 (7), 965-971, 2010
Safety and tolerability of antipsychotic polypharmacy
JA Gallego, J Nielsen, M De Hert, JM Kane, CU Correll
Expert opinion on drug safety 11 (4), 527-542, 2012
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta‐analysis and meta‐regression analysis
B Galling, A Roldan, K Hagi, L Rietschel, F Walyzada, W Zheng, XL Cao, ...
World Psychiatry 16 (1), 77-89, 2017
The validity of the schizophrenia diagnosis in the Danish Psychiatric Central Research Register is good
P Uggerby, SD Østergaard, R Røge, CU Correll, J Nielsen
Dan Med J 60 (2), A4578, 2013
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles
JI Goldstein, L Fredrik Jarskog, C Hilliard, A Alfirevic, L Duncan, ...
Nature communications 5 (1), 1-9, 2014
Assessing QT interval prolongation and its associated risks with antipsychotics
J Nielsen, C Graff, JK Kanters, E Toft, D Taylor, JM Meyer
CNS drugs 25 (6), 473-490, 2011
Optimizing clozapine treatment
J Nielsen, P Damkier, H Lublin, D Taylor
Acta Psychiatrica Scandinavica 123 (6), 411-422, 2011
Augmentation of clozapine with a second antipsychotic–a meta‐analysis
DM Taylor, L Smith, SH Gee, J Nielsen
Acta Psychiatrica Scandinavica 125 (1), 15-24, 2012
Risk factors for ileus in patients with schizophrenia
J Nielsen, JM Meyer
Schizophrenia bulletin 38 (3), 592-598, 2012
Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?
R Røge, BK Møller, CR Andersen, CU Correll, J Nielsen
Schizophrenia research 140 (1-3), 204-213, 2012
Consensus statement on the use of clozapine during the COVID-19 pandemic
D Siskind, WG Honer, S Clark, CU Correll, A Hasan, O Howes, JM Kane, ...
Journal of Psychiatry and Neuroscience 45 (3), 222-223, 2020
Abuse potential of pregabalin
O Schjerning, M Rosenzweig, A Pottegård, P Damkier, J Nielsen
CNS drugs 30 (1), 9-25, 2016
Worldwide differences in regulations of clozapine use
J Nielsen, C Young, P Ifteni, T Kishimoto, YT Xiang, PFJ Schulte, ...
CNS drugs 30 (2), 149-161, 2016
Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management
S Fanoe, D Kristensen, A Fink-Jensen, HK Jensen, E Toft, J Nielsen, ...
European heart journal 35 (20), 1306-1315, 2014
Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine-or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical …
JR Larsen, L Vedtofte, MSL Jakobsen, HR Jespersen, MI Jakobsen, ...
JAMA psychiatry 74 (7), 719-728, 2017
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20